These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 159020)

  • 1. D-penicillamine and immune complex deposition.
    Kirby JD; Dieppe PA; Huskisson EC; Smith B
    Ann Rheum Dis; 1979 Aug; 38(4):344-6. PubMed ID: 159020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus during penicillamine therapy for rheumatoid arthritis.
    Chalmers A; Thompson D; Stein HE; Reid G; Patterson AC
    Ann Intern Med; 1982 Nov; 97(5):659-63. PubMed ID: 6958210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penicillamine-induced lupus-like reaction in rheumatoid arthritis and vasculitis.
    Thorvaldsen J
    Dermatologica; 1981; 162(4):277-80. PubMed ID: 6455314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [D-penicillamine induced lupus during the treatment of rheumatoid arthritis. Report of 2 cases and systematic immunologic study during the treatment].
    Crouzet J; Camus JP; Leca AP; Guillien P; Lièvre JA
    Ann Med Interne (Paris); 1974 Jan; 125(1):71-9. PubMed ID: 4136184
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic lupus erythematosus-like syndrome with focal proliferative glomerulonephritis during D-penicillamine therapy.
    Donnelly S; Levison DA; Doyle DV
    Br J Rheumatol; 1993 Mar; 32(3):251-3. PubMed ID: 8448620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillamine induced lupus-like syndrome in a patient with classical rheumatoid arthritis.
    Chin GL; Kong NC; Lee BC; Rose IM
    J Rheumatol; 1991 Jun; 18(6):947-8. PubMed ID: 1895285
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus.
    Borg AA; Davis MJ; Dawes PT; Shadforth MF
    Clin Rheumatol; 1994 Sep; 13(3):522-4. PubMed ID: 7835022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lupus biology: incidence and development in 84 rheumatoid polyarthritis patients treated with D-penicillamine].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Ann Med Interne (Paris); 1984; 135(6):420-6. PubMed ID: 6334465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-penicillamine and lupus erythematosuslike syndrome.
    Harkcom TM; Conn DL; Holley KE
    Ann Intern Med; 1978 Dec; 89(6):1012. PubMed ID: 717982
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis.
    Essigman WK
    Ann Rheum Dis; 1982 Dec; 41(6):617-20. PubMed ID: 6216862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine?
    Sturfelt G; Rydgren L; Truedsson L; Alm P; Sjöholm AG
    J Rheumatol; 1996 Feb; 23(2):378-81. PubMed ID: 8882051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
    Weinstein A; Rothfield NF
    J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complications of D-penicillamine treatment of rheumatoid poly-arthritis].
    Camus JP; Crouzet J; Prier A; Leca AP
    Therapie; 1976; 31(3):385-97. PubMed ID: 136767
    [No Abstract]   [Full Text] [Related]  

  • 14. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapy and circulating immune complexes in rheumatoid arthritis.
    Bacon PA
    Rheumatol Rehabil; 1978; Suppl():53-8. PubMed ID: 364612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
    Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
    Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients.
    Schroeter AL; Conn DL; Jordon RE
    Ann Rheum Dis; 1976 Aug; 35(4):321-6. PubMed ID: 970989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of penicillamine on the kidney.
    Davison AM; Day AT; Golding JR; Thomson D
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):109-13. PubMed ID: 122655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillamine-induced polymyositis-dermatomyositis.
    Petersen J; Halberg P; Højgaard K; Lyon BB; Ullman S
    Scand J Rheumatol; 1978; 7(2):113-7. PubMed ID: 705267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated antigalactosyl antibody titers reflect renal injury after gold or D-penicillamine in rheumatoid arthritis.
    Malaise MG; Davin JC; Mahieu PR; Franchimont P
    Clin Immunol Immunopathol; 1986 Aug; 40(2):356-64. PubMed ID: 2941196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.